Mise Koki, Hoshino Junichi, Ueno Toshiharu, Sumida Keiichi, Hiramatsu Rikako, Hasegawa Eiko, Yamanouchi Masayuki, Hayami Noriko, Suwabe Tatsuya, Sawa Naoki, Fujii Takeshi, Hara Shigeko, Ohashi Kenichi, Takaichi Kenmei, Ubara Yoshifumi
Nephrology Center, Toranomon Hospital, Tokyo, Japan.
Nephrology Center, Toranomon Hospital, Tokyo, Japan.
Diabetes Res Clin Pract. 2014 Dec;106(3):522-30. doi: 10.1016/j.diabres.2014.09.051. Epub 2014 Oct 7.
The kidneys of patients with diabetes mellitus usually exhibit a characteristic pattern of linear immunofluorescent staining for immunoglobulin G (IgG) along the glomerular and tubular basement membranes. However, the association between linear IgG staining and the renal prognosis remains unclear.
Among 223 patients with diabetes who underwent renal biopsy from 1985 to 2010 and were confirmed to have pure diabetic nephropathy according to the classification of Tervaert et al., 165 patients (glomerular classes I to III) were enrolled in this study. Immunofluorescent staining was classified into three categories according to its intensity (0=none, 1=weakly positive, and 2=positive). Cox proportional hazards regression analysis was used to calculate the hazard ratio (HR) and 95% confidence interval (CI) for death-censored renal death, with each regression analysis employing four levels of multivariate adjustment.
After adjustment for important clinical factors at the time of renal biopsy, the HR for death-censored renal death in patients with an IgG staining score of 1 or 2 was, respectively, 3.01 (95% CI: 1.05-8.68) and 4.68 (1.67-13.1) compared with patients who had a staining score of 0. Even after adjustment for clinical variables and pathological findings, the HR for IgG score of 1 or 2 was higher than that for an IgG score of 0, and it was, respectively, 2.22 (0.71-7.00) and 3.76 (1.27-11.2).
More intense linear IgG staining is associated with a higher HR for renal death, which suggests that linear immunofluorescent staining for IgG may be a prognostic indicator in patients with diabetic nephropathy.
糖尿病患者的肾脏通常在肾小球和肾小管基底膜上呈现免疫球蛋白G(IgG)线性免疫荧光染色的特征性模式。然而,线性IgG染色与肾脏预后之间的关联仍不清楚。
在1985年至2010年接受肾活检且根据特尔瓦特等人的分类确诊为单纯糖尿病肾病的223例糖尿病患者中,165例(肾小球分级I至III级)纳入本研究。免疫荧光染色根据其强度分为三类(0 =无,1 =弱阳性,2 =阳性)。采用Cox比例风险回归分析计算死亡删失的肾脏死亡的风险比(HR)和95%置信区间(CI),每次回归分析采用四个水平的多变量调整。
在对肾活检时的重要临床因素进行调整后,与染色评分为0的患者相比,IgG染色评分为1或2的患者死亡删失的肾脏死亡的HR分别为3.01(95%CI:1.05 - 8.68)和4.68(1.67 - 13.1)。即使在对临床变量和病理结果进行调整后,IgG评分为1或2的HR仍高于IgG评分为0的HR,分别为2.22(0.71 - 7.00)和3.76(1.27 - 11.2)。
更强的线性IgG染色与更高的肾脏死亡HR相关,这表明IgG的线性免疫荧光染色可能是糖尿病肾病患者的一个预后指标。